These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38754591)

  • 1. Temporal trends in the contribution of modifiable cardiovascular risk factors to cardiovascular and all-cause mortality in patients undergoing myocardial perfusion imaging in a large city in Brazil.
    Fernandes-Silva MM; Conti-Pelanda JD; Vosgerau LM; Cunha GSP; Vercka KC; Crestani A; Goedert GM; Cerci RJ; Silvestre OM; Nadruz W; Vitola JV
    Int J Cardiol; 2024 Aug; 409():132178. PubMed ID: 38754591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
    Yusuf S; Joseph P; Rangarajan S; Islam S; Mente A; Hystad P; Brauer M; Kutty VR; Gupta R; Wielgosz A; AlHabib KF; Dans A; Lopez-Jaramillo P; Avezum A; Lanas F; Oguz A; Kruger IM; Diaz R; Yusoff K; Mony P; Chifamba J; Yeates K; Kelishadi R; Yusufali A; Khatib R; Rahman O; Zatonska K; Iqbal R; Wei L; Bo H; Rosengren A; Kaur M; Mohan V; Lear SA; Teo KK; Leong D; O'Donnell M; McKee M; Dagenais G
    Lancet; 2020 Mar; 395(10226):795-808. PubMed ID: 31492503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in population attributable fraction of modifiable risk factors for cardiovascular diseases across three decades.
    Zhu F; Boersma E; Tilly M; Ikram MK; Qi H; Kavousi M
    Eur J Prev Cardiol; 2024 Oct; 31(14):1724-1733. PubMed ID: 38935527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging.
    Poulin MF; Alexander S; Doukky R
    J Nucl Cardiol; 2016 Apr; 23(2):202-11. PubMed ID: 25788401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.
    Roger G; Ducrocq G; Mesnier J; Sayah N; Abtan J; Ferrari R; Ford I; Fox KM; Tardif JC; Tendera M; Feldman LJ; Elbez Y; Steg PG;
    Eur Heart J; 2024 Jul; 45(27):2396-2406. PubMed ID: 39193886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy.
    Lopez-Jaramillo P; Joseph P; Lopez-Lopez JP; Lanas F; Avezum A; Diaz R; Camacho PA; Seron P; Oliveira G; Orlandini A; Rangarajan S; Islam S; Yusuf S
    Eur Heart J; 2022 Aug; 43(30):2841-2851. PubMed ID: 35325078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of death and associated risk factors among climacteric women from Southern Brazil: a population based-study.
    Colpani V; Oppermann K; Spritzer PM
    BMC Public Health; 2014 Feb; 14():194. PubMed ID: 24559309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging.
    Bourque JM; Patel CA; Ali MM; Perez M; Watson DD; Beller GA
    Circ Cardiovasc Imaging; 2013 May; 6(3):466-77. PubMed ID: 23547172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran.
    Eslami A; Naghibi Irvani SS; Ramezankhani A; Fekri N; Asadi K; Azizi F; Hadaegh F
    BMC Public Health; 2019 Jun; 19(1):719. PubMed ID: 31182076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between polygenic risk of coronary artery disease and type 2 diabetes, lifestyle, and cardiovascular mortality: A prospective UK Biobank study.
    Yun JS; Jung SH; Shivakumar M; Xiao B; Khera AV; Park WY; Won HH; Kim D
    Front Cardiovasc Med; 2022; 9():919374. PubMed ID: 36061534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging.
    Ghatak A; Padala S; Katten DM; Polk DM; Heller GV
    J Nucl Cardiol; 2013 Aug; 20(4):529-38. PubMed ID: 23703380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends of stress myocardial perfusion imaging: Influence of diabetes, gender and coronary artery disease status.
    Chhabra L; Ahlberg AW; Henzlova MJ; Duvall WL
    Int J Cardiol; 2016 Jan; 202():922-9. PubMed ID: 26492159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes.
    Ives CW; AlJaroudi WA; Kumar V; Farag A; Rizk DV; Oparil S; Iskandrian AE; Hage FG
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1998-2008. PubMed ID: 29882159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy.
    Joseph P; Kutty VR; Mohan V; Kumar R; Mony P; Vijayakumar K; Islam S; Iqbal R; Kazmi K; Rahman O; Yusuf R; Anjana RM; Mohan I; Rangarajan S; Gupta R; Yusuf S
    Eur Heart J; 2022 Aug; 43(30):2831-2840. PubMed ID: 35731159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death.
    Piccini JP; Horton JR; Shaw LK; Al-Khatib SM; Lee KL; Iskandrian AE; Borges-Neto S
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):180-8. PubMed ID: 19808541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study.
    Sardarinia M; Akbarpour S; Lotfaliany M; Bagherzadeh-Khiabani F; Bozorgmanesh M; Sheikholeslami F; Azizi F; Hadaegh F
    PLoS One; 2016; 11(12):e0167623. PubMed ID: 27930696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years.
    Koshy AN; Gow PJ; Han HC; Teh AW; Jones R; Testro A; Lim HS; McCaughan G; Jeffrey GP; Crawford M; Macdonald G; Fawcett J; Wigg A; Chen JWC; Gane EJ; Munn SR; Clark DJ; Yudi MB; Farouque O
    Eur Heart J Qual Care Clin Outcomes; 2020 Oct; 6(4):243-253. PubMed ID: 32011663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy.
    Roumeliotis AK; Roumeliotis SK; Panagoutsos SA; Tsetsos F; Georgitsi M; Manolopoulos V; Paschou P; Passadakis PS
    Int Urol Nephrol; 2018 Feb; 50(2):321-329. PubMed ID: 29196930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study.
    Ku IA; Farzaneh-Far R; Vittinghoff E; Zhang MH; Na B; Whooley MA
    Atherosclerosis; 2011 Aug; 217(2):503-8. PubMed ID: 21176905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.